slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 30,691-30,720
Pages 1,418
Rows per page 30
Beat
30,691-30,720 of 42,534
33
The chart highlights a clear trend of improving profitability, specifically showing Adj. EBITDA moving toward zero.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
34
The slide highlights a 'pandemic bump' and a significant reduction in burn rate.Grove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
11
Hagerty | Investor Presentation Deck | 18 slidesHagerty | Investor Presentation Deck | 18 slides · Hagerty
Conference presentation Investor relations Beat · The AskLoop · Quick Win Big Bet1 hit
09
HeartBeam | Results Presentation Deck | 10 slidesHeartBeam | Results Presentation Deck | 10 slides · HeartBeam
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet1 hit
10
HeartBeam | Results Presentation Deck | 10 slidesHeartBeam | Results Presentation Deck | 10 slides · HeartBeam
Conference presentation Investor relations Beat · Action1 hit
39
Heartland Financial USA | Results Presentation Deck | 53 slidesHeartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
40
The slide uses a standard corporate identity structure for mission/vision/values.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Voice Of Customer1 hit
41
The slide uses icons to categorize ESG metrics.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Voice Of Customer1 hit
15
The slide highlights a 53% currency-adjusted increase in inventory levels.Hugo Boss | Results Presentation Deck | 22 slides · Hugo Boss
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
16
The slide uses a three-column layout to present key financial performance indicators.Hugo Boss | Results Presentation Deck | 22 slides · Hugo Boss
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
17
The slide uses a stylized repetition of the year '2023' as a design element.Hugo Boss | Results Presentation Deck | 22 slides · Hugo Boss
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
18
The slide uses a before-after comparison to show an upward revision in financial guidance.Hugo Boss | Results Presentation Deck | 22 slides · Hugo Boss
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
19
The slide uses a before-after framing to highlight the increase in EBIT guidance.Hugo Boss | Results Presentation Deck | 22 slides · Hugo Boss
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
20
The slide uses a repeating '2023' visual motif on the left and a brand image on the right.Hugo Boss | Results Presentation Deck | 22 slides · Hugo Boss
Conference presentation Investor relations Beat · Ultimate AchievementLoop · Quick Win Big Bet1 hit
05
The slide uses a hub-and-spoke layout to surround the product image with key value propositions.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
06
Hyperfine | Investor Presentation Deck | 16 slidesHyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
15
The table includes both GAAP financial metrics and supplemental non-GAAP/operational data.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
16
The data shows a significant spike in legal/consulting/accounting fees in Q2 2023 due to SEC investigation accruals.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
17
The table includes footnotes explaining specific adjustments to the figures.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
18
Hyzon | Results Presentation Deck | 19 slidesHyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
19
The table includes adjustments for fair value changes, stock-based compensation, and legal/regulatory matters.Hyzon | Results Presentation Deck | 19 slides · Hyzon
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
10
The slide uses a side-by-side comparison of two proprietary technology platforms.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
11
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
12
The slide uses a matrix structure to compare clinical outcomes against three key value propositions.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
13
Includes comparative bar charts and flow cytometry data.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
14
Includes a comparison table of clinical outcomes (ORR/CR) for NXC-201 vs competitors.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
15
Immix Biopharma | Investor Presentation Deck | 46 slidesImmix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
16
The slide compares two disease indications side-by-side with clinical metrics and competitive market context.Immix Biopharma | Investor Presentation Deck | 46 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
22
The chart demonstrates deepening clinical responses over time for NXC-201 therapy.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit